Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT07202273
Status
Recruiting
Apply to this trial

Conditions

  • Bone Metastases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • simulation-free, single-fraction palliative radiation therapy — RADIATION
    Radiation will be delivered in a single fraction. The recommended prescription dose is 8 Gy with external beam radiation therapy. Up to two sites of bone metastases may be treated on trial (i.e. no more than two radiation portals). Each site may have multiple lesions.

Study Details

The goal of this study is to provide proof that patients can be treated with simulation-free, single-fraction palliative radiation therapy with a single in-person visit.

Key Dates

First listed
Oct 1, 2025
Start date
Nov 3, 2025
Status verified
Aug 2026
Primary completion
Oct 31, 2027
Completion
Oct 31, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Simulation-free, single-fraction palliative radiation therapy

Primary Outcome Measure

To assess the rate at which the intervention is delivered with fidelity to protocol. [ Time Frame: 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Huntsman Cancer Institute/University of UtahSalt Lake CityUtah84112
Rachel Kingsford
[email protected]
801-585-0115
Shane Lloyd, MD
[email protected]
801-585-0255

Find similar trials in Salt Lake City, UT

By research site
Huntsman Cancer Institute/University of Utah· Salt Lake City, UT

Related Studies